Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilars in Oncology: Latest Trends and Regulatory Status.
Joshi D, Khursheed R, Gupta S, Wadhwa D, Singh TG, Sharma S, Porwal S, Gauniyal S, Vishwas S, Goyal S, Gupta G, Eri RD, Williams KA, Dua K, Singh SK. Joshi D, et al. Among authors: singh sk, singh tg. Pharmaceutics. 2022 Dec 5;14(12):2721. doi: 10.3390/pharmaceutics14122721. Pharmaceutics. 2022. PMID: 36559215 Free PMC article. Review.
Impact of solidification on micromeritic properties and dissolution rate of self-nanoemulsifying delivery system loaded with docosahexaenoic acid.
Ghosh D, Singh SK, Khursheed R, Pandey NK, Kumar B, Kumar R, Kumari Y, Kaur G, Clarisse A, Awasthi A, Gulati M, Jain SK, Porwal O, Bayrakdar E, Sheet M, Gowthamarajan K, Gupta S, Corrie L, Gunjal P, Gupta RK, Singh TG, Sinha S. Ghosh D, et al. Among authors: singh sk, singh tg. Drug Dev Ind Pharm. 2020 Apr;46(4):597-605. doi: 10.1080/03639045.2020.1742143. Epub 2020 Mar 23. Drug Dev Ind Pharm. 2020. PMID: 32162980
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.
Vishwas S, Gulati M, Kapoor B, Gupta S, Singh SK, Awasthi A, Khan A, Goyal A, Bansal A, Baishnab S, Singh TG, Arora S, Porwal O, Kumar A, Kumar V. Vishwas S, et al. Among authors: singh sk, singh tg. Curr Neuropharmacol. 2021;19(7):957-989. doi: 10.2174/1570159X18666201109090824. Curr Neuropharmacol. 2021. PMID: 33167841 Free PMC article. Review.
Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression.
Satija S, Kaur H, Tambuwala MM, Sharma P, Vyas M, Khurana N, Sharma N, Bakshi HA, Charbe NB, Zacconi FC, Aljabali AA, Nammi S, Dureja H, Singh TG, Gupta G, Dhanjal DS, Dua K, Chellappan DK, Mehta M. Satija S, et al. Among authors: singh tg. Curr Mol Pharmacol. 2021;14(3):321-332. doi: 10.2174/1874467214666210120154929. Curr Mol Pharmacol. 2021. PMID: 33494692 Review.
A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations.
Joshi D, Sharma I, Gupta S, Singh TG, Dhiman S, Prashar A, Gulati M, Kumar B, Vishwas S, Chellappan DK, Gupta G, Jha NK, Gupta PK, Negi P, Dua K, Singh SK. Joshi D, et al. Among authors: singh sk, singh tg. Environ Sci Pollut Res Int. 2021 Nov;28(42):59608-59629. doi: 10.1007/s11356-021-16345-5. Epub 2021 Sep 13. Environ Sci Pollut Res Int. 2021. PMID: 34515931 Free PMC article. Review.
Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead.
Jena R, Vishwas S, Kumar R, Kaur J, Khursheed R, Gulati M, Singh TG, Vanathi BM, Alam A, Kumar B, Chaitanya MVNL, Gupta S, Negi P, Pandey NK, Bhatt S, Gupta G, Chellappan DK, Oliver BG, Dua K, Singh SK. Jena R, et al. Among authors: singh sk, singh tg. Eur J Pharmacol. 2022 Sep 15;931:175173. doi: 10.1016/j.ejphar.2022.175173. Epub 2022 Aug 6. Eur J Pharmacol. 2022. PMID: 35940236 Review.
160 results